Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Abnormal Proliferation02:23

Abnormal Proliferation

5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Overview of Exosomes01:36

Overview of Exosomes

3.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

BI 905711, a TRAILR2/CDH17 Bispecific Antibody, Alone or with Chemotherapy for Patients with Advanced Gastrointestinal Cancers: Phase I Study Findings.

Cancer research communications·2026
Same author

Lenalidomide-rituximab or lenalidomide-rituximab-bendamustine for relapsed/refractory follicular lymphoma: primary and final analysis of the randomized phase II HOVON110/ReBeL study.

Haematologica·2026
Same author

Reviving CD2 signaling to boost CAR T-cell therapy.

Blood·2026
Same author

Functional cooperation between the B-cell receptor and NOTCH1 in regulating metabolic reprogramming in chronic lymphocytic leukemia.

Leukemia·2026
Same author

Single-cell genomics highlight MYC-associated metabolic activation and altered cell interactions in T-prolymphocytic leukemia progression.

Nature communications·2026

Related Experiment Video

Updated: Feb 25, 2026

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

10.7K

Tumor-derived exosomes modulate PD-L1 expression in monocytes.

Franziska Haderk1, Ralph Schulz1, Murat Iskar1

  • 1Department of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Science Immunology
|July 30, 2017
PubMed
Summary

Tumor cell exosomes in chronic lymphocytic leukemia (CLL) transfer noncoding RNA hY4 to monocytes, promoting cancer-promoting inflammation and immune evasion via programmed cell death 1 ligand 1 (PD-L1) expression.

More Related Videos

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

8.2K
Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes
09:30

Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes

Published on: May 24, 2019

7.9K

Related Experiment Videos

Last Updated: Feb 25, 2026

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

10.7K
Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

8.2K
Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes
09:30

Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes

Published on: May 24, 2019

7.9K

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Monocytes and macrophages in chronic lymphocytic leukemia (CLL) exhibit protumorigenic characteristics.
  • These cells release tumor-supportive cytokines and express immunosuppressive molecules like programmed cell death 1 ligand 1 (PD-L1).

Purpose of the Study:

  • To investigate the mechanism by which tumor cell-derived exosomes drive protumorigenic skewing in monocytes within the CLL microenvironment.
  • To identify specific exosomal components responsible for modulating monocyte function.

Main Methods:

  • RNA sequencing and proteome analysis of exosomes isolated from CLL patient plasma.
  • Co-culture experiments with CLL-derived exosomes or purified hY4 RNA and monocytes (wild-type and Toll-like receptor 7-deficient).
  • In vitro and in vivo studies assessing the impact of endosomal Toll-like receptor (TLR) signaling inhibition on monocyte activation and CLL development.

Main Results:

  • Noncoding Y RNA hY4 was identified as a highly abundant RNA species enriched in exosomes from CLL patients.
  • Transfer of CLL exosomes or hY4 induced CLL-associated monocyte phenotypes, including cytokine release (CCL2, CCL4, IL-6) and PD-L1 expression.
  • These effects were dependent on Toll-like receptor 7 (TLR7) signaling, and inhibition of endosomal TLR signaling attenuated monocyte activation and CLL progression.

Conclusions:

  • Exosome-mediated transfer of noncoding RNA hY4 contributes to cancer-related inflammation in CLL.
  • This process facilitates immune escape through PD-L1 upregulation on monocytes.
  • Targeting exosomal noncoding RNAs and endosomal TLR signaling presents a potential therapeutic strategy for CLL.